Global Head Hemophilia
Centessa Pharmaceuticals
Trevor Baglin is a co-inventor of SerpinPC and is involved in its clinical development through his role as Global Head of Hemophilia at Centessa Pharmaceuticals. He was a clinician in the United Kingdom National Health Service for 35 years, including 20 years as the Director of the Comprehensive Care Centre for Hemophilia in Cambridge, UK. It was during this time that he envisioned the development of a factor agnostic subcutaneous prophylactic modality as a possible way to improve the standard of care for persons with hemophilia, including those with limited access to factor concentrates. He served as President of the British Society for Haematology and also the British Society for Thrombosis and Haemostasis. He was a Founder of the European Congress for Thrombosis and Haemostasis and served as an Elected Member (Class of 2009) of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.